• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析 COVID-19 发病机制中的免疫细胞和标志物特征:最新进展。

The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update.

机构信息

Medical Laboratory Techniques Department, Al-Maarif University College, Al-Anbar-Ramadi, Iraq.

Department of Pathology, College of Medicine, University of Babylon, Hilla, Iraq.

出版信息

J Med Virol. 2022 Nov;94(11):5128-5148. doi: 10.1002/jmv.28000. Epub 2022 Jul 23.

DOI:10.1002/jmv.28000
PMID:35835586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9350195/
Abstract

The precise interaction between the immune system and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical in deciphering the pathogenesis of coronavirus disease 2019 (COVID-19) and is also vital for developing novel therapeutic tools, including monoclonal antibodies, antivirals drugs, and vaccines. Viral infections need innate and adaptive immune reactions since the various immune components, such as neutrophils, macrophages, CD4 T, CD8 T, and B lymphocytes, play different roles in various infections. Consequently, the characterization of innate and adaptive immune reactions toward SARS-CoV-2 is crucial for defining the pathogenicity of COVID-19. In this study, we explain what is currently understood concerning the conventional immune reactions to SARS-CoV-2 infection to shed light on the protective and pathogenic role of immune response in this case. Also, in particular, we investigate the in-depth roles of other immune mediators, including neutrophil elastase, serum amyloid A, and syndecan, in the immunopathogenesis of COVID-19.

摘要

免疫系统与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)之间的精确相互作用对于解析 2019 年冠状病毒病(COVID-19)的发病机制至关重要,对于开发新型治疗工具(包括单克隆抗体、抗病毒药物和疫苗)也至关重要。病毒感染需要先天和适应性免疫反应,因为各种免疫成分(如中性粒细胞、巨噬细胞、CD4T、CD8T 和 B 淋巴细胞)在各种感染中发挥不同的作用。因此,对 SARS-CoV-2 的先天和适应性免疫反应进行特征分析对于确定 COVID-19 的致病性至关重要。在这项研究中,我们解释了目前对 SARS-CoV-2 感染的常规免疫反应的理解,以阐明在这种情况下免疫反应的保护和致病作用。此外,我们特别研究了其他免疫介质(包括中性粒细胞弹性蛋白酶、血清淀粉样蛋白 A 和 syndecan)在 COVID-19 免疫发病机制中的深入作用。

相似文献

1
The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update.解析 COVID-19 发病机制中的免疫细胞和标志物特征:最新进展。
J Med Virol. 2022 Nov;94(11):5128-5148. doi: 10.1002/jmv.28000. Epub 2022 Jul 23.
2
Immune response induced by novel coronavirus infection.新型冠状病毒感染诱导的免疫应答。
Front Cell Infect Microbiol. 2022 Oct 25;12:988604. doi: 10.3389/fcimb.2022.988604. eCollection 2022.
3
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.雾化卡介苗接种对恒河猴 SARS-CoV-2 挑战后免疫和疾病参数的影响。
Front Immunol. 2022 Feb 9;12:801799. doi: 10.3389/fimmu.2021.801799. eCollection 2021.
4
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.固有免疫和适应性免疫对 SARS-CoV-2 及相关影响因素。
Front Immunol. 2023 May 9;14:1159326. doi: 10.3389/fimmu.2023.1159326. eCollection 2023.
5
The laboratory tests and host immunity of COVID-19 patients with different severity of illness.不同疾病严重程度的 COVID-19 患者的实验室检测和宿主免疫。
JCI Insight. 2020 May 21;5(10):137799. doi: 10.1172/jci.insight.137799.
6
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).关于冠状病毒病 (COVID-19) 期间免疫反应和衰竭的综合综述。
Cell Commun Signal. 2022 Jun 2;20(1):79. doi: 10.1186/s12964-022-00856-w.
7
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
8
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.《关于 2019 年冠状病毒病的被动免疫:包括恢复期血浆在内的治疗方面的述评》
Semin Thromb Hemost. 2020 Oct;46(7):796-803. doi: 10.1055/s-0040-1712157. Epub 2020 Jun 11.
9
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives.SARS-CoV-2 感染中的先天和适应性免疫反应——当前的观点。
Front Immunol. 2022 Nov 22;13:1053437. doi: 10.3389/fimmu.2022.1053437. eCollection 2022.
10
Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.COVID-19 免疫发病机制中的树突状细胞:对其在决定疾病结局中可能起作用的深入了解。
Int Rev Immunol. 2021;40(1-2):108-125. doi: 10.1080/08830185.2020.1844195. Epub 2020 Nov 16.

引用本文的文献

1
Dynamics of Innate Immunity in SARS-CoV-2 Infections: Exploring the Impact of Natural Killer Cells, Inflammatory Responses, Viral Evasion Strategies, and Severity.新型冠状病毒感染中固有免疫的动力学:探究自然杀伤细胞、炎症反应、病毒逃避策略及疾病严重程度的影响
Cells. 2025 May 22;14(11):763. doi: 10.3390/cells14110763.
2
Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies.吡唑并三嗪衍生物作为潜在抗SARS-CoV-2药物的药物重新利用:体外和计算机模拟研究。
BMC Chem. 2024 Jul 16;18(1):132. doi: 10.1186/s13065-024-01233-z.
3
The central role of neutrophil extracellular traps (NETs) and by-products in COVID-19 related pulmonary thrombosis.中性粒细胞胞外诱捕网(NETs)及其产物在 COVID-19 相关肺血栓形成中的核心作用。
Immun Inflamm Dis. 2023 Aug;11(8):e949. doi: 10.1002/iid3.949.
4
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection.营养物质、草药生物活性衍生物和共生微生物群作为降低新型冠状病毒感染风险的工具。
Front Nutr. 2023 Jun 1;10:1152254. doi: 10.3389/fnut.2023.1152254. eCollection 2023.
5
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID.调节性T细胞(Tregs)与新冠病毒病(COVID-19):揭示其机制及治疗潜力,特别关注新冠后综合征
Vaccines (Basel). 2023 Mar 19;11(3):699. doi: 10.3390/vaccines11030699.
6
Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients.血清干扰素-γ和RNA血症时间曲线作为实体器官移植患者和免疫功能正常患者中重症新冠肺炎的生物标志物
J Infect. 2023 May;86(5):529-533. doi: 10.1016/j.jinf.2023.01.019. Epub 2023 Jan 21.

本文引用的文献

1
BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality.BNT162b2 诱导的记忆 T 细胞对奥密克戎变异株的反应具有保存的多功能性。
Nat Microbiol. 2022 Jun;7(6):909-917. doi: 10.1038/s41564-022-01123-x. Epub 2022 May 16.
2
Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development.严重 COVID-19 患者发生肺纤维化时外周血单个核细胞及可溶性因子的变化。
Front Immunol. 2022 Apr 26;13:831194. doi: 10.3389/fimmu.2022.831194. eCollection 2022.
3
Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19.单细胞转录组学揭示了一种独特的记忆样 NK 细胞亚群,该亚群随着年龄的增长而积累,并与 COVID-19 中的疾病严重程度相关。
Genome Med. 2022 May 3;14(1):46. doi: 10.1186/s13073-022-01049-3.
4
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity.根据疾病严重程度,COVID-19 后 1 年的免疫反应不同。
Front Immunol. 2022 Mar 21;13:830433. doi: 10.3389/fimmu.2022.830433. eCollection 2022.
5
Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.COVID-19 患者外周血单个核细胞中调节炎症的基因表达和组蛋白甲基化改变的特征。
J Immunol. 2022 Apr 15;208(8):1968-1977. doi: 10.4049/jimmunol.2101099. Epub 2022 Apr 4.
6
The immunology and immunopathology of COVID-19.新型冠状病毒肺炎的免疫学和免疫病理学。
Science. 2022 Mar 11;375(6585):1122-1127. doi: 10.1126/science.abm8108. Epub 2022 Mar 10.
7
COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches.COVID-19 免疫疗法:基于免疫细胞介导方法的治疗。
Int Immunopharmacol. 2022 Jun;107:108655. doi: 10.1016/j.intimp.2022.108655. Epub 2022 Feb 25.
8
The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis.肿瘤坏死因子-α、白细胞介素-6与维生素D水平与新型冠状病毒肺炎严重程度及死亡率之间的关联:一项系统评价与Meta分析
Pathogens. 2022 Feb 1;11(2):195. doi: 10.3390/pathogens11020195.
9
The T cell immune response against SARS-CoV-2.针对 SARS-CoV-2 的 T 细胞免疫应答。
Nat Immunol. 2022 Feb;23(2):186-193. doi: 10.1038/s41590-021-01122-w. Epub 2022 Feb 1.
10
Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients.嗜酸性粒细胞增多与吸入性皮质类固醇治疗患者 COVID-19 结局改善相关。
J Allergy Clin Immunol Pract. 2022 Mar;10(3):742-750.e14. doi: 10.1016/j.jaip.2021.12.034. Epub 2022 Jan 13.